UF’s 135 matches include 94 PGY1 and 41 PGY2.
The awards come from various federal institutions, but all 10 have at least one grant from the National Institutes of Health, or NIH.
More than 50 Pharm.D. students and several faculty traveled across the country to represent UF at one of the nation’s largest pharmacy meetings.
The model allows scientists to assess complex interactions of large data that can reveal hidden patterns and generate more accurate predictions in clinical settings.
UF College of Pharmacy faculty and trainees also won a best paper award and multiple poster awards.
The conference attracted more than 200 attendees representing various interests in health care.
More than 20 speakers shared personal stories and recounted the scientific impacts that made Derendorf a respected leader.
The Centers for Medicare and Medicaid Services criteria are used to flag high-risk patients for opioid abuse and overdose.
The center will unite researchers interested in using big data to evaluate drugs and the safety of medications in real-world populations.
The study, published in the journal Hepatology, examined the clinical and economic outcomes of direct-acting antiviral therapy, which cures hepatitis C in nearly 95 percent of patients.